# Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2)

> **NCT01798121** · PHASE2 · UNKNOWN · sponsor: **JHP Pharmaceuticals LLC** · enrollment: 90 (estimated)

## Conditions studied

- Tuberculosis Identification.

## Interventions

- **BIOLOGICAL:** To compare new PPD to reference standard material
- **BIOLOGICAL:** Reference standard

## Key facts

- **NCT ID:** NCT01798121
- **Lead sponsor:** JHP Pharmaceuticals LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2013-03
- **Final completion:** 2013-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2013-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01798121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01798121, "Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01798121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*